Product Profile of Autologous Limbal Stem Cell Composite Graft

Reliance Life Sciences offers Autologous Limbal Stem Cell Composite Graft. Reliance Life Sciences supplies Biopharmaceuticals, Plasma Proteins, Biosimilars, Pharmaceuticals, Oncology Products, Steroids, Hormones, Peptides, Formulations, Regenerative Medicine, etc. The Autologous Limbal Stem Cell Composite Graft of model name ReliNethra is the first stem cell-based therapy in the country. It is an autologous limbal stem cell composite graft, prepared from the limbal biopsy excised from the healthy eye of the patient. ReliNethra comprises of limbal epithelial stem cells cultured ex vivo on human amniotic membrane [HAM].

This Autologous Limbal Stem Cell Composite Graft is used for treating eyes infected with:

• Chemical burns

• Thermal burns

• Mechanical injuries to cornea

• Ionizing radiation injuries

• Multiple surgical procedures or cryotherapies affecting the limbal region

• Contact lens-induced keratopathy

• Severe microbial keratitis

• Stevens-Johnson syndrome